Trials / Completed
CompletedNCT05004337
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (VANISH)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 126 (actual)
- Sponsor
- Natera, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin
Conditions
Timeline
- Start date
- 2021-07-22
- Primary completion
- 2023-11-29
- Completion
- 2023-11-29
- First posted
- 2021-08-13
- Last updated
- 2024-09-25
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05004337. Inclusion in this directory is not an endorsement.